Emerging Technologies: Healthcare Communication Friend or Foe?
Embracing emerging technologies and innovations is not just an option but a necessity for biopharma, HCPs, and organizations looking to thrive in the digital age...
Read MoreTop Stories
Cactus Life Sciences Announces the Acquisition
FOR IMMEDIATE RELEASE Princeton, NJ, April 24, 2024 - Cactus...
Cactus Life Sciences Appoints Oliver Dennis to
Princeton, NJ, April 16, 2024 - Cactus Life Sciences, a...
Optimizing Medical Affairs with Modular Content:
Turn your organization into an “efficiency powerhouse” with...
Filter
Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements
HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...
HEOR in 2022: The Importance of Data Visualization, RWD, and Interactive Formats
Effectively communicating data in the pharmaceutical and medical community is vital to payer engagement. Learn...
Pharma, Physician, and Patient Pain Points Regarding Clinical Trials
Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?
A majority of patients feel lay summaries for clinical trials are very important and won’t...
3 Factors That Will Help Pharma Build Public Trust
Pharma must engage with patients at all levels to build public trust...